Does Dr. ANNICK AUBIN-POULIOT have financial conflicts of interest?

Dr. ANNICK AUBIN-POULIOT (MD) has received a total of $1,494 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,494 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ANNICK AUBIN-POULIOT?

According to CMS Open Payments data, Dr. ANNICK AUBIN-POULIOT received funding from GLAXOSMITHKLINE ($362), ALK-ABELLO ($239), and REGENERON HEALTHCARE SOLUTIONS ($219).

Does Dr. ANNICK AUBIN-POULIOT receive research grants or speaking fees?

Dr. ANNICK AUBIN-POULIOT has received $1,494 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ANNICK AUBIN-POULIOT

MDReal-Time Hydrated

Specialty: Otolaryngology

Practice Location: SANTA ROSA, CA 95404

NPI Number: 1205213170

LIFETIME INDUSTRY VALUE

$1,494

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AUBIN-POULIOT is a verified Otolaryngology practitioner based in SANTA ROSA, CA.

Between 2021 and 2024, Dr. AUBIN-POULIOT had an overall industry promotional and research financial footprint of $1,494 as recorded in the federal CMS Open Payments database.

$1,494 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AUBIN-POULIOT's primary funding source is GLAXOSMITHKLINE, which accounts for $362 (representing 24.2% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GLAXOSMITHKLINE

Rank 1

$362

24.2%

ALK-ABELLO

Rank 2

$239

16%

REGENERON HEALTHCARE SOLUTIONS

Rank 3

$219

14.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.